Anika Therapeutics, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$24Mgeneral payments (2019-2025)
$22Kresearch payments (2019-2025)
2,464clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $92K
2020 $16M
2021 $2.2M
2022 $3.2M
2023 $1.6M
2024 $1.1M
2025 $363K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery $14M
Sports Medicine (Orthopaedic Surgery) $5.3M
Interventional Cardiology $1.1M
Hand Surgery $796K
Surgery $645K
Foot & Ankle Surgery $543K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Anthony Miniaci Cleveland, OH Orthopaedic Surgery $2,232,797.80
Anthony Buonanno Johnston, RI Orthopaedic Surgery $1,953,168.22
Garrett Lynch Annapolis, MD Sports Medicine (Orthopaedic Surgery) $1,378,259.94
Craig Walker Houma, LA Interventional Cardiology $920,023.34
Scott Graham Laguna Woods, CA Sports Medicine (Orthopaedic Surgery) $877,543.78
Carleton Vangsness Los Angeles, CA Sports Medicine (Orthopaedic Surgery) $871,349.36
Christopher Proctor Santa Barbara, CA Orthopaedic Surgery $671,062.90
Randall Peyton Sterling, VA Orthopaedic Surgery $645,252.79
Brian Mckeon Waltham, MA Orthopaedic Surgery $634,952.78
Neil Maki Thibodaux, LA Orthopaedic Surgery $619,442.68

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.